| Literature DB >> 30517946 |
Frank A Giordano1, Grit Welzel2, Victor Siefert2, Lennart Jahnke3, Thomas Ganslandt4, Frederik Wenz2, Anca-Ligia Grosu5,6, Felix Heinemann5,6, Nils H Nicolay5,6.
Abstract
There is accumulating evidence from randomized trials suggesting that digital patient-centered care allows a more reliable detection of tumour-related symptoms and adverse events - with a direct impact on overall survival. Consequently, a variety of unsynchronized approaches were kicked off to (electronically) measure patient-reported outcomes (PROs). Despite increasing evidence that PRO data are highly relevant for patient care, the data generated in these initial projects lack standardized processing pathways in order to impact clinical routine; therefore, potential future routine PRO assessments require adequate analysis, storage and processing to allow a robust, reproducible and reliable incorporation into routine clinical decision-making. Here, we discuss relevant challenges of digital follow-up that need to be tackled to render PRO data as relevant to physicians as laboratory or biomarker data.Entities:
Keywords: Digital care; Digital follow-up; Patient-reported outcomes
Mesh:
Year: 2018 PMID: 30517946 DOI: 10.1159/000495294
Source DB: PubMed Journal: Oncology ISSN: 0030-2414 Impact factor: 2.935